Gilgamesh Pharma Raises $60M to Fund Its Remaining Neuropsychiatric Assets
NEW YORK – Gilgamesh Pharma, the clinical-stage neuroscience company formed ...
NEW YORK – Gilgamesh Pharma, the clinical-stage neuroscience company formed ...
LOS ANGELES- Industrial hemp has more ROI potential than the ...
CHICAGO- CannaLaugh, a live event series combining nationally touring stand-up ...
LONG BEACH – In a sector still adjusting to ongoing ...
NEW YORK – After a year that delivered the first ...
VANCOUVER – In a Canadian Cannabis market that continues to ...
CHELMSFORD – The Cannabist Co. Holdings Inc. signed definitive agreements ...
WASHINGTON – The Wine & Spirits Wholesalers of America (WSWA), ...
BRUSSELS – The European Medicines Agency (EMA) has granted Priority ...
MINNEAPOLIS – In a move that instantly reshapes the competitive ...